Biotech Breakout

Back in mid-July we posted some thoughts on the biotech sector. We suspected that the correction may have run its course and that the worst was over. Recent action gives further evidence that biotech may begin to perform more in…continue reading

Death by a Thousand Cuts

Much has been written about the average investor’s inability to “beat the market” and to earn substantial wealth investing in the markets.  Personally, I have had my share of success and failures in the market but have nonetheless  done well…continue reading